Publications by authors named "Malcolm Peet"

16Publications

Omega-3 polyunsaturated fatty acids in the treatment of schizophrenia.

Authors:
Malcolm Peet

Isr J Psychiatry Relat Sci 2008 ;45(1):19-25

Swallownest Court Hospital, Sheffield, Great Britain.

View Article

Download full-text PDF

Source
August 2008

Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder.

Aust N Z J Psychiatry 2008 Mar;42(3):192-8

Department of Nutrition and Biochemistry, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00048670701827275DOI Listing
March 2008

Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.

J Clin Psychiatry 2006 Dec;67(12):1954-67

Women's Mental Health Program, Department of Psychiatry, University of Arizona College of Medicine, Tucson 85724-5002, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/jcp.v67n1217DOI Listing
December 2006

The metabolic syndrome, omega-3 fatty acids and inflammatory processes in relation to schizophrenia.

Authors:
Malcolm Peet

Prostaglandins Leukot Essent Fatty Acids 2006 Oct-Nov;75(4-5):323-7. Epub 2006 Aug 28.

Doncaster and South Humber Healthcare NHS Trust, Rotherham Services, Early Intervention Service, Swallownest, Sheffield, S26 4TH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.plefa.2006.07.013DOI Listing
January 2007

Nutrition and schizophrenia.

Authors:
Malcolm Peet

World Rev Nutr Diet 2005 ;95:17-28

Doncaster and South Humber NHS Trust, Sheffield, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000088267DOI Listing
December 2005

Omega-3 fatty acids in the treatment of psychiatric disorders.

Drugs 2005 ;65(8):1051-9

Swallownest Court Hospital, Doncaster and South Humber Healthcare NHS Trust, Sheffield, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00003495-200565080-00002DOI Listing
November 2005

Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms.

Nutr Neurosci 2004 Aug;7(4):247-9

Rotherham Mental Health Services, Swallownest Court, Sheffield, S26 4TH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10284150400010012DOI Listing
August 2004

Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients.

World J Biol Psychiatry 2004 Apr;5(2):92-9

Rotherham Mental Health Services, Swallownest Court, Aughton Road, Sheffield, S26 4TH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15622970410029917DOI Listing
April 2004

International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis.

Authors:
Malcolm Peet

Br J Psychiatry 2004 May;184:404-8

Swallownest Court Hospital, Aughton Road, Sheffield S26 4TH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1192/bjp.184.5.404DOI Listing
May 2004

Diet, diabetes and schizophrenia: review and hypothesis.

Authors:
Malcolm Peet

Br J Psychiatry Suppl 2004 Apr;47:S102-5

Swallownest Court Hospital, Aughton Road, Sheffield S26 4TH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1192/bjp.184.47.s102DOI Listing
April 2004

Nutrition and schizophrenia: beyond omega-3 fatty acids.

Authors:
Malcolm Peet

Prostaglandins Leukot Essent Fatty Acids 2004 Apr;70(4):417-22

Swallownest Court Hospital, Aughton Road, Sheffield S26 4th, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.plefa.2003.12.019DOI Listing
April 2004

Nutrition and schizophrenia: an epidemiological and clinical perspective.

Authors:
Malcolm Peet

Nutr Health 2003 ;17(3):211-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/026010600301700304DOI Listing
March 2004

Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results.

Authors:
Malcolm Peet

Prostaglandins Leukot Essent Fatty Acids 2003 Dec;69(6):477-85

Swallownest Court Hospital, Aughton Road, Sheffield S26 4TH, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.plefa.2003.08.020DOI Listing
December 2003

The man who walks backwards.

J R Soc Med 2002 Mar;95(3):137

University Department of Psychiatry, Longley Centre, Norwood Grange Drive, Sheffield S5 7JT, UK.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1279484PMC
http://dx.doi.org/10.1258/jrsm.95.3.137DOI Listing
March 2002

A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms.

J Psychiatr Res 2002 Jan-Feb;36(1):7-18

Swallownest Court, Aughton Road, S26 4TH, Sheffield, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0022-3956(01)00048-6DOI Listing
February 2002